Three-time UFC flyweight competitor Priscila Cachoeira has accepted a four-month suspension for an anti-doping violation stemming from an out of competition drug test, USADA announced Wednesday.
Cachoeira tested positive hydrochlorothiazide (HCTZ) and its metabolites chlorothiazide and 4amino-6chloro-1,3-benzenedisulfonamide (ACB), which are in the category of diuretics and masking agents. The Brazilian received a reduced sanction because she was able to prove that the positive test was a result of a blood pressure medication.
Her four-month suspension is retroactive to Oct. 12, the date the positive sample was collected. Cachoeira will be eligible to return to active competition in February.